SCHEMBL2907527

SCHEMBL2907527

C[C@@H](O)CNC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.36
GSK3B P49841 4/20 0.35
GSK3A P49840 3/20 0.35
ACSS2 Q9NR19 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CDK1 P06493 2/20 0.32
CCNB2 O95067 1/20 0.32
CCNB1 P14635 1/20 0.32
CCNB3 Q8WWL7 1/20 0.32
NTRK1 P04629 3/20 0.31
JAK2 O60674 2/20 0.31
MET P08581 2/20 0.31
AXL P30530 1/20 0.31
MAPT P10636 1/20 0.31
ACVR1B P36896 1/20 0.31
ACVRL1 P37023 1/20 0.31
LMNA P02545 1/20 0.31
SCN10A Q9Y5Y9 1/20 0.30
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912211 1.00 TGFBR1 (0.36) TGFBR1GSK3BGSK3AACSS2SMN1; SMN2
SCHEMBL2912584 0.93 GSK3B (0.40) TGFBR1GSK3BGSK3AACSS2SMN1; SMN2
SCHEMBL2913229 0.93 GSK3B (0.40) TGFBR1GSK3BGSK3AACSS2SMN1; SMN2
SCHEMBL2911262 0.93 GSK3B (0.42) TGFBR1GSK3BGSK3ASMN1; SMN2ALDH1A1
SCHEMBL2907739 0.93 GSK3B (0.42) TGFBR1GSK3BGSK3ASMN1; SMN2ALDH1A1
SCHEMBL2911304 0.93 GSK3B (0.35) TGFBR1GSK3BGSK3AACSS2SMN1; SMN2
SCHEMBL2912314 0.93 GSK3B (0.35) TGFBR1GSK3BGSK3AACSS2SMN1; SMN2
SCHEMBL2909381 0.92 MAPT (0.38) GSK3BGSK3AACSS2SMN1; SMN2ALDH1A1
SCHEMBL2907210 0.92 MAPT (0.38) GSK3BGSK3AACSS2SMN1; SMN2ALDH1A1
SCHEMBL2908179 0.90 MET (0.34) GSK3BGSK3AACSS2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed